The Prime Form RETA 20MG features Retatrutide 20MG, a research peptide studied for its activity as a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors. Designed for laboratory and scientific research, this product is ideal for studies focused on metabolic function, energy regulation, weight management mechanisms, and advanced peptide research applications.

Key Features:

Contains Retatrutide 20MG
Research-grade quality and purity
Suitable for metabolic and endocrinology research
Triple agonist peptide for advanced scientific studies
Lyophilized powder for laboratory applications
Securely packaged for research use

Research Use Only. Not for human consumption.